A synthetic peptide (SP-10-IIIB) with an amino acid sequence [Cys-Thr-Arg-Pro-Asn-Asn-
Asn-Thr-Arg-Lys-Ser-Ile-Arg-Ile-Gln-Arg-Gly-Pro-Pro-Gly-(Tyr); amino acids 303-321] from …

In previous studies, we have used antisera raised to envelope (env)-gene-encoded
synthetic peptides to identify a region of (HIV) glycoprotein (gp) 120 env protein designated …

Two synthetic peptides containing amino acid sequences analogous to the envelope
glycoprotein of human T‐lymphotropic virus (HTLV) type III (HTLV‐III) and lymphadenopathy …

We have previously described a synthetic peptide (T1-SP10) derived from two
noncontiguous regions of HTLVIIIB envelope gp120 (T1, amino acids 428-443; SP10, amino …

Much effort has been devoted to the analysis of antibodies to acquired immunodeficiency
syndrome virus antigens, but no studies, to our knowledge, have defined antigenic sites of …

Four major neutralizing regions of the human immunodeficiency virus type 1 (HIV-1)
envelope glycoprotein were identified and characterized with a panel of 80 HIV-1 antibody …

Sera from individuals infected by HIV-1 usually neutralize multiple viral isolates. To
determine the extent to which these neutralizing antibodies recognize a principal …

Chimpanzees are susceptible to infection by divergent strains of human immunodeficiency
virus type 1 (HIV-1), none of which cause clinical or immunological abnormalities …

Repeated immunizations of goats, horses, or chimpanzees with envelope glycoprotein
gp120 isolated from human immunodeficiency virus type 1 (HIV-1) resulted in type-specific …

The principal neutralizing determinant (PND) of human immunodeficiency virus (HIV)-1
resides within the V3 loop of the envelope protein. Antibodies elicited by peptides of this …